Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy

Clinical trial NCT00676650 · TERMINATED

Trial details

NCT number: NCT00676650
Sponsor: Pfizer
Status: TERMINATED
Phase: Phase 3
Study type: INTERVENTIONAL

Prostatic Neoplasms

Start date: 2008-07-01
Primary completion: 2011-12-01
Enrollment: 873

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.